Pediatric disease burden and vaccination recommendations: understanding local differences

International Journal of Infectious Diseases

Volumn 14, Issue 8, 2010, Pages

  Gentile, Angela ^a   Bhutta, Zulfiqar ^b   Bravo, Lulu ^c   Samy, Aly Gamal ^d   Garcia, R Dennis J ^e   Hoosen, Anwar ^f   Islam, Tazul ^g   Karimi, Abdollah ^h   Salem, Mona ^d   Simasathien, Sriluck ⁱ   Sohail, Amir ^j   Watanaveeradej, Veerachai ^k   Wiedenmayer, Karin ^l   Schmitt, Heinz J ^m  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b AGA KHAN UNIVERSITY   (Pakistan)

^c UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^d AIN SHAMS UNIVERSITY   (Egypt)

^e MAKATI MEDICAL CENTER   (Philippines)

^f UNIVERSITY OF PRETORIA   (South Africa)

^g EPI Mohakhali   (Bangladesh)

^h SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁱ Pediatric Infectious Diseases Society of Thailand   (Thailand)

^j Phramongkutklao Hospital ^*  (Bangladesh)

^k PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^l SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^m Global Medical Affairs   (Germany)

more..

Author keywords

Diphtheria; Haemophilus influenzae type b; Hepatitis B; Measles; Pertussis; Tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; MEASLES VACCINE; BACTERIAL VACCINE; VACCINE; VIRUS VACCINE;

AFRICA; ASIAN; CHILDHOOD DISEASE; DIPHTHERIA; GEOGRAPHY; HAEMOPHILUS INFLUENZAE TYPE B INFECTION; HEALTH SURVEY; HEPATITIS B; HUMAN; INFLUENZA; MEASLES; PERTUSSIS; REVIEW; SOUTHEAST ASIA; TETANUS; VACCINATION; WESTERN EUROPE; WESTERN HEMISPHERE; WORLD HEALTH ORGANIZATION; CHILD; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH; HEALTH CARE PLANNING; IMMUNIZATION; IMMUNOLOGY; INCIDENCE; PROCEDURES; STATISTICS AND NUMERICAL DATA; WHOOPING COUGH;

BACTERIAL VACCINES; CHILD; DIPHTHERIA; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PLANNING GUIDELINES; HEPATITIS B; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; MEASLES; TETANUS; VACCINATION; VACCINES, COMBINED; VIRAL VACCINES; WHOOPING COUGH; WORLD HEALTH; WORLD HEALTH ORGANIZATION; GLOBAL HEALTH;

EID: 77954957120     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.11.006     Document Type: Review

References (76)

1. Centers for Disease Control and Prevention (CDC). Epidemiology and prevention of vaccine-preventable diseases [Diphtheria]. 10th ed. Washington, DC: Public Health Foundation; 2008:pp. 50-70. Available at: (accessed April 1, 2009). http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/dip.pdf.
2. World Health Organization (WHO). Immunization surveillance, assessment and monitoring. Diphtheria. Geneva: WHO; 2010. Available at: (accessed February 10 2010). http://www.who.int/immunization_monitoring/diseases/diphteria/en/index.html.
3. Bleck T.P. Clostridium tetani (Tetanus). Principles and practice of infectious diseases 2005, 2817-2822. Churchill Livingstone, Philadelphia, USA. 6th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
4. Centers for Disease Control and Prevention (CDC). Epidemiology and prevention of vaccine-preventable diseases [Tetanus]. 10th ed. Washington, DC: Public Health Foundation; 2008 pp. 273-282. Available at: (accessed February 10, 2010). http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/tetanus.pdf.
5. World Health Organization (WHO). Immunization surveillance, assessment and monitoring. Tetanus. Geneva: WHO; 2010. Available at: (accessed February 10, 2009). http://www.who.int/immunization_monitoring/diseases/tetanus/en/index.html.
6. World Health Organization (WHO). Pertussis vaccines. WHO position paper. Wkly Epidemiol Rec 2005;80:29-40.
7. World Health Organization (WHO). Immunization surveillance, assessment and monitoring. Pertussis. Geneva: WHO; 2010. Available at: (accessed February 10, 2010). http://www.who.int/immunization_monitoring/diseases/pertussis/en/index.html.
8. World Health Organization (WHO). Hepatitis B vaccines. WHO position paper. Wkly Epidemiol Rec 2004;79:255-63.
9. World Health Organization (WHO). Immunization surveillance, assessment and monitoring. Hepatitis B. Geneva: WHO; 2010. Available at: (accessed February 10, 2010). http://www.who.int/immunization_monitoring/diseases/hepatitis/en/index.html.
10. World Health Organization (WHO). Hepatitis B. Fact sheet No. 204. Geneva: WHO; 2008. Available at: (accessed February 10, 2010). http://www.who.int/mediacentre/factsheets/fs204/en/index.html.
11. World Health Organization (WHO). Haemophilus influenzae type B (Hib). Fact sheet No. 294. Geneva: WHO; 2005. Available at: (accessed April 1, 2009). http://www.who.int/mediacentre/factsheets/fs294/en/index.html.
12. World Health Organization (WHO). WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 2006; 81:445-52.
13. World Health Organization (WHO). Measles. Fact sheet No. 286. Geneva: WHO; 2009. Available at: (accessed February 10, 2010). http://www.who.int/mediacentre/factsheets/fs286/en/index.html.
14. World Health Organization (WHO). Immunization surveillance, assessment and monitoring. Measles. Geneva: WHO; 2010. Available at: (accessed February 10, 2010). http://www.who.int/immunization_monitoring/diseases/measles/en/index.html.
15. st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000, 13:302-317.
16. Lattanzi M., Rappuoli R. Novel vaccination strategies. The grand challenge for the future 2005, 77-98. Birkhäuser Verlag, Basel, Switzerland. S.H. Kaufmann, P.H. Lambert (Eds.).
17. Global Polio Eradication Initiative (GPEI). Background: The history. Available at: (accessed April 1, 2009). http://www.polioeradication.org/history.asp.
18. World Health Organization (WHO). WHO position paper on diphtheria. Wkly Epidemiol Rec 2006;81:21-32.
19. World Health Organization (WHO). WHO position paper on tetanus. Wkly Epidemiol Rec 2006;81:197-208.
20. World Health Organization (WHO). WHO position paper on measles. Wkly Epidemiol Rec 2006;79:129-44.
21. World Health Organization (WHO). Immunization against diseases of public health importance. Fact sheet No. 288. Geneva: WHO; 2005. Available at: (accessed April 1, 2009). http://www.who.int/mediacentre/factsheets/fs288/en/index.html.
22. GAVI Alliance. Immunisation. Geneva: GAVI; 2006. Available at: (accessed April 1, 2009). http://www.gavialliance.org/resources/FS_Immunisation_Aug06_en.pdf.
23. Wiedenmayer K.A., Weiss S., Chattopadhyay C., Mukherjee A., Kundu R., Ayé R., et al. Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: evidence from a comparative time-motion study in India. Vaccine 2009, 27:655-659.
24. Kalies H., Grote V., Verstraeten T., Hessel L., Schmitt H.J., von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006, 25:507-512.
25. Bloom D.E., Canning D., Weston M. The value of vaccination. World Economics 2005, 6:15-39.
26. World Health Organization (WHO). Estimated annual incidence for selected causes: by sex, age and WHO subregion, 2002. World health report 2004. Geneva: WHO; 2004. Available at: (accessed April 1, 2009). http://www.who.int/healthinfo/statistics/gbdwhoregionincidence2002.xls.
27. World Health Organization (WHO). Global and regional immunization profile. African Region. Geneva: WHO; 2008. Available at: (accessed April 1, 2009). http://www.who.int/immunization_monitoring/en/globalsummary/GS_AFRProfile.pdf.
28. World Health Organization (WHO). Global and regional immunization profile. Region of the Americas. Geneva: WHO; 2008. Available at: (accessed April 1, 2009). http://www.who.int/immunization_monitoring/en/globalsummary/GS_AMRProfile.pdf.
29. World Health Organization (WHO). Global and regional immunization profile. Eastern Mediterranean Region. Geneva: WHO; 2008. Available at: (accessed April 1, 2009). http://www.who.int/immunization_monitoring/en/globalsummary/GS_EMRProfile.pdf.
30. World Health Organization (WHO). Global and regional immunization profile. European Region. Geneva: WHO; 2008. Available at: (accessed April 1, 2009). http://www.who.int/immunization_monitoring/en/globalsummary/GS_EURProfile.pdf.
31. World Health Organization (WHO). Global and regional immunization profile. South-East Asia Region. Geneva: WHO; 2008. Available at: (accessed April 1, 2009). http://www.who.int/immunization_monitoring/en/globalsummary/GS_SEAProfile.pdf.
32. World Health Organization (WHO). Global and regional immunization profile. Western Pacific Region. Geneva: WHO; 2008. Available at: (accessed April 1, 2009). http://www.who.int/immunization_monitoring/en/globalsummary/GS_WPRProfile.pdf.
33. World Health Organization (WHO). WHO vaccine preventable diseases monitoring system. 2008 Global summary. Geneva: WHO; 2008. Available at: (accessed April 1, 2009). http://www.who.int/vaccines/globalsummary/immunization/countryprofileselect.cfm.
34. World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system. 2007 global summary. Geneva: WHO; 2007. Available at: (accessed April 1, 2009). http://www.who.int/immunization/documents/WHO_IVB_2007/en/index.html.
35. World Health Organization (WHO) WHO position paper on pneumococcal conjugate vaccine for childhood immunization. Wkly Epidemiol Rec 2006, 82:93-104.
36. Republic of South Africa Department of Health. Statistical notes. South Africa: Department of Health; 2005. Available at: (accessed April 1, 2009). http://www.doh.gov.za/facts/stats-notes/2005/hepb.pdf.
37. Boletín epidemiológico anual. Ministro de salud de la nacion, Argentina. 2006. Inmunoprevinibles. Available at: (accessed December 1, 2008). http://www.msal.gov.ar/htm/Site/sala_situacion/PANELES/boletines/bepAnual/BEPanual2006_Inmunoprev.pdf.
38. Ali S.A., Donahue R.M., Qureshi H., Vermund S.H. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009, 13:9-19.
39. Nizami S.Q., Bhutta Z.A., Hasan R. Incidence of acute respiratory infections in children 2 months to 5 years of age in periurban communities in Karachi. Pakistan. J Pak Med Assoc 2006, 56:163-167.
40. Ministry of Health, Saudi Arabia. Statistics year book 2006. A review of health situation. Saudi Arabia: Ministry of Health; 2006. Available at: (accessed April 1, 2009). http://www.moh.gov.sa/statistics/S1427/Chapter%201.pdf.
41. Liver Foundation of Bangladesh. Hepatitis B. Bangladesh: Liver Foundation; 2006. Available at: (accessed April 1, 2009). http://www.liver.org.bd/Hepatitis-B.asp%3FSP=LM%26VW=1.
42. Rerks-Ngarm S., Treleaven S.C., Chunsuttiwat S., Muangchana C., Jolley D., Brooks A., et al. Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand. Vaccine 2004, 22:975-983.
43. Bureau of Epidemiology, Thailand. Annual epidemiological surveillance report 2007. Thailand: Ministry of Health; 2007. Available at: (accessed September 1, 2008). http://epid.moph.go.th/.
44. Limcangco M.R., Salole E.G., Armour C.L. Epidemiology of Haemophilus influenzae type b meningitis in Manila, Philippines, 1994 to 1996. Pediatr Infect Dis J 2000, 19:7-11.
45. Redwan el-RM, Elsawy A. Surveillance of natural acquired antibodies to Haemophilus influenzae type b among children in Cairo-Egyptian. Hum Antibodies 2005, 14:23-26.
46. Lansang M.A. Epidemiology and control of hepatitis B infection: a perspective from the Philippines. Asia. Gut 1996, 38(Suppl 2):S43-S47.
47. Bhutta Z.A. Burden of Haemophilus influenzae and Streptococcus pneumoniae infections during childhood in Pakistan. J Coll Physicians Surg Pak 2000, 10:346-354.
48. Quddus A., Luby S., Rahbar M., Pervaiz Y. Neonatal tetanus: mortality rate and risk factors in Loralai District. Pakistan. Int J Epidemiol 2002, 31:648-653.
49. World Health Organization (WHO). Catalogue of immunization policy recommendations [pertussis, diphtheria, and measles]. Geneva: WHO; 2008. Available at: (accessed April 1, 2009). http://www.who.int/immunization/policy/en/.
50. Murphy T.V., Slade B.A., Broder K.R., Kretsinger K., Tiwari T., Joyce P.M., et al. Centers for Disease Control and Prevention (CDC). Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008, 57(RR-4):1-51. Advisory Committee on Immunization Practices (ACIP).
51. UNdata. Neonates protected at birth against neonatal tetanus. Philippines 2006. United Nations Statistics Division; 2008. Available at: (accessed April 1, 2009). http://data.un.org/Data.aspx%3Fd=WHO%26f=inID%253AHSC04.
52. Corrigall J., Coetzee D., Cameron N. Is the Western Cape at risk of an outbreak of preventable childhood diseases? Lessons from an evaluation of routine immunisation coverage. S Afr Med J 2008, 98:41-45.
53. Siedler A., Tischer A., Mankertz A., Santibanez S. Two outbreaks of measles in Germany 2005. Euro Surveill 2006, 11:131-134.
54. Richard J.L., Spicher V.M. Ongoing measles outbreak in Switzerland: results from November 2006 to July 2007. Euro Surveill 2007, 12:1. E070726.
55. Schmid D., Holzmann H., Abele S., Kasper S., König S., Meusburger S., et al. An ongoing multi-state outbreak of measles linked to non-immune anthroposophic communities in Austria, Germany, and Norway, March-April 2008. Euro Surveill 2008, 13:1-2.
56. Parker A.A., Staggs W., Dayan G.H., Ortega-Sánchez I.R., Rota P.A., Lowe L., et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 2006, 355:447-455.
57. Pearce A., Law C., Elliman D., Cole T.J. Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study. BMJ 2008, 336:754-757. Bedford H; Millennium Cohort Study Child Health Group.
58. World Health Organization (WHO) Vaccine Preventable Diseases Monitoring System. Immunization schedules by antigen. Geneva: WHO; 2009. Available at: (accessed April 1, April 2009). http://www.who.int/immunization_monitoring/data/schedule_data.xls.
59. World Health Organization (WHO). WHO/UNICEF Regional Child Survival Strategy: accelerated and sustained action towards MDG 4. Geneva: WHO; 2006. Available at: (accessed April 1, 2009). http://www.wpro.who.int/NR/rdonlyres/BAA52CCD-88B6-4D8B-9BC8-F9F64C963213/0/FinalRegionalChildSurvivalStrategy.pdf.
60. Adegbola R.A., Secka O., Lahai G., Lloyd-Evans N., Njie A., Usen S., et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005, 366:144-150.
61. Lewis R.F., Kisakye A., Gessner B.D., Duku C., Odipio J.B., Iriso R., et al. Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda. Bull World Health Organ 2008, 86:292-301.
62. Lim S.S., Stein D.B., Charrow A., Murray C.J. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lancet 2008, 372:2031-2046.
63. Gellin B.G., Maibach E.W., Marcuse E.K. Do parents understand immunizations? A national telephone survey. Pediatrics 2000, 106:1097-1102.
64. Decker M.D., Edwards K.M., Bogaerts H.H. Combination vaccines. Vaccines 2008, 1069-1101. Saunders, Philadelphia, USA. 5th ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
65. Lugo N.R., Montoya C., Koslap-Petraco M.B. Parents' perspectives on immunizations: a survey. American Journal for Nurse Practitioners 2003, 7:8-19.
66. Kanra G., Kara A., Demiralp O., Contorni M., Hilbert A.K., Spyr C., et al. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Hum Vaccin 2006, 2:155-160.
67. Blatter MM, Reisinger KS, Terwelp DR, DelBuono FJ, Howe BJ. Immunogenicity of a combined diphtheria-tetanus-acellular pertussis (DT-tricomponent Pa)-hepatitis B (HB)-inactivated poliovirus (IPV) admixed with Haemophilus influenzae type b (Hib) vaccine in infants. The American Pediatric Society and the Society for Pediatric Research meeting, May 1-5, 1998, New Orleans, USA. Pediatr Res 1998;43(4 part 2):141A. [abstract].
68. Arístegui J., Dal-Ré R., Díez-Delgado J., Marés J., Casanovas J.M., García-Corbeira P., et al. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age. Vaccine 2003, 21:3593-3600.
69. Black S, Nakasato C, Davis R, France E, Schuerman L, Jacquet JM, et al. Two large phase III, multicenter trials comparing primary vaccination with DTPa-HBV-IPV/Hib versus commercially available vaccines administered at separate sites. Poster presentation. 4th World Congress of the World Society for Pediatric Infectious Diseases (WSPID), September 1-4, 2005, Warsaw, Poland.
70. Olin P., Rasmussen F., Gustafsson L., Hallander H.O., Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 1997, 350:1569-1577.
71. Southern J., McVernon J., Gelb D., Andrews N., Morris R., Crowley-Luke A., et al. Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy. Clin Vaccine Immunol 2007, 14:1328-1333.
72. Rieber N., Graf A., Belohradsky B.H., Hartl D., Urschel S., Riffelmann M., et al. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination. Vaccine 2008, 26:6929-6935.
73. Jefferson T., Rudin M., DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003, 21:2003-2014.
74. International Finance Facility for Immunisation (IFFIm). Update 3: June 2008. Available at: (accessed April 1, 2009). http://www.iff-immunisation.org/pdfs/update3_3GBweb.pdf.
75. GAVI Alliance. GAVI Alliance progress report 2007. Geneva: GAVI; 2007. Available at: (accessed April 1, 2009). http://www.gavialliance.org/resources/2007GAVIreport.pdf.
76. World Health Organization (WHO). Global immunization news (GIN). Geneva: WHO; 2007. Available at: (Accessed 1st April 2009). http://www.who.int/immunization/GIN_October2007.pdf.